Online
|
|
BIOCON
पोस्ट करनेवाले :
pshah-2012According to Fibonacci, BIOCON has a support of 212.28/211.3/209.72 and resistance of 215.45/216.43/218.02. Its currently trading at 216.35 is UP by 0.16%. SRC: TradersCockpit...
Analysts question Biocon`s treatment of Pfizer compensation
पोस्ट करनेवाले :
boarder77This too will pass away. Remember that old BG saying - "short term voting m/c but long term weighing m/c". The sentiments were worse in Wockhardt in 2009 when it went below 80. Look what the same operators are now up to....
Biocon
पोस्ट करनेवाले : boarder77One sensible remark in what otherwise has been a fish market . Remember the Enzyme biz sale and the tax obligation. This time around KMS has made the most of that one "development of insulin being ongoing" clause to steer clear of the tax man. If that "rogue" call of 186 comes true I will have more shares of Biocon in my portfolio and that`s a promise!...
Biocon
पोस्ट करनेवाले :
stocktinthe problem with this idiotic kms is she is always focused on the wrong things as investors of biocon we are not interested in knowing whether that chusa hua aam chirag is a rogue or not what we wish to know from her is she a rogue or not. she shd have logically shredded the report to pieces answering all the negatives that chirag mentions abt biocon.my limited inteligence and common sense tells me for the pfizer licencing she cd have said that as per the agreement it is our responsibility to bring this product to the market therefore we are netting the licencing against exp and when we sign agreements with regional partners that amt will come as clean income in our p&l...
Biocon
पोस्ट करनेवाले : pandit-acharayadri must probe this lady....
Biocon
पोस्ट करनेवाले : pandit-acharayawhat a shameful position for biocon under kms,the so called lady of ethics.have you ever seen murty ji,prem ji,anu aga ji appearing to media for such money stashing conspiracy clarifications.this is the real face of this cheap lady.and i am awareing you all for last 1 year.how dare this cheap lady can count her self with them....
Analysts question Biocon`s treatment of Pfizer compensation
पोस्ट करनेवाले : ramanujam11
I doubt any inquiry seems likely. It is a debatable issue and I am sure the auditors would have discussed and taken a decision. The agreement with Pfizer is vital and interpretation comes later. I am sure the auditors would have studied the deal agreement. Others who now comment may not be aware of clauses and I am sure the company will solve this issue soon.
...
quite right and it also creates another problem since the boss has spoken there can be no fall back measure and now nobody beleives a word he says...
PERCEPTION IS REALITY in the markets. I agree completly time for investor relations to step in and clear the confusion....
